Aegis Critical Energy Defence Corp. announced it has no share purchase warrants outstanding and enough cash to fund its operations and marine power program for over 30 months without raising capital. The company is developing hybrid energy systems using small and micro modular reactors, supported by a $480,000 research program with Ontario Tech University. Ongoing negotiations with international shipbuilders and a Canadian industrial partner aim to integrate these power systems into vessels and joint products. Insider trading blackout remains until these talks conclude or are no longer needed.
Aegis Critical Energy Defence Corp.'s recent update on its financial stability and negotiations is provided here alongside Pluang's energy sector market data for context. For readers following energy stocks, here is Pluang's market snapshot as of Sep 17, 2026 19:12 WIB: out of 30 priced US energy stocks, 10 rose and 18 fell. Notable prices include Valero Energy Corporation (VLO) at USD 400.20 with a 1-day change of -0.76%, Devon Energy Corp (DVN) at USD 48.08 with a 1-day change of -0.74%, and Occidental Petroleum Corporation (OXY) at USD 58.93 with a 1-day change of -0.72%.
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...
More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...
Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...
Nokia reported third-quarter 2026 earnings per share of $0.10, surpassing the $0.08 estimate, and revenue of $5.78 billion, exceeding the $5.72 billion forecast. The company's AI and cloud sales surged 123%, driven by high demand for its IP Networks ...
